The FDA has accepted for review the sBLA for subcutaneous lecanemab-irmb as a weekly starting dose for Alzheimer disease.

The FDA has set a Prescription Drug User Fee Act action date for 24 May 2026.

Monash University researchers alongside key partner Halozyme Therapeutics have reported findings in support of shifting the way anti-cancer ...

Gwyneth Paltrow, 53, touted a popular longevity ingredient, beloved among tech bros and fitness influencers, as her latest ...

Monash University researchers alongside key partner Halozyme Therapeutics have reported findings in support of shifting the way anti-cancer ...

From GLP-1 injections to NAD+ infusions, Boston has become ground zero for the longevity obsession—where everyone from Back ...

“What to do with a spouse who doesn’t imbibe, who doesn’t like crowds or noisy restaurants, and who doesn’t overindulge on sugary desserts? First off, we jettison the traditions that I, too, can live ...

The FDA approved daratumumab and hyaluronidase-fihj (Darzalex Faspro) in combination with bortezomib (Velcade), lenalidomide ...

A $1.558 trillion National budget was presented yesterday in 6 ½ hours by Dr Ashni Singh, Minister in the Office of the ...

Many peptides are produced either by compounding pharmacies in the U.S. or by an ever-growing number of factories in China. The most serious users tend to get peptides from the latter for both a wider ...

Huahui Health announced that China National Medical Products Administration (NMPA) has granted conditional approval to its Libevitug injection for the treatment of chronic hepatitis D virus infection ...

Medical plastic compounds are poised for robust growth driven by rising demand for single-use disposables, minimally invasive devices and customized implants. Key growth factors comprise escalating ...